FitBit
Casdin Capital
Bessemer Venture Partners
Singtel partners Bridge Alliance to offer GPU-as-a-Service in South-east Asia
Submitted by Priya Khosla on August 20, 2024 - 5:07am
Southeast Asia’s leading telcos AIS, Maxis and Telkomsel are among the alliance’s early adopters to cater to the growing demand for AI computing in Thailand, Malaysia and Indonesia respectively, having signalled their interest in the service.
Nicholas Mitrokostas
Partner
A & O Shearman
Nick is the Managing Partner of the Boston office and an experienced Life Sciences trial attorney who focuses on representing innovator companies in intellectual property, trade secret, licensing and antitrust disputes. A litigator known for his trial skills, Nick has been lead counsel and gone to trial in dozens of ANDA and BPCIA litigations and has extensive experience representing clients in the pharmaceutical, biotechnology, and medical device industries in federal and state courts as well as before the Patent Trial and Appeal Board (PTAB). Nick also has expertise in counseling emerging and small and mid-cap Life Sciences companies in late stage drug development on issues pertaining to patent and regulatory exclusivities including patent term extension (PTE), patent listing requirements, and pre-commercial and launch assessments and litigation risks.
Gemma Barrett
Partner
A & O Shearman
Gemma is an experienced and trusted advisor for some of the world’s leading life sciences and chemical companies. Her background in biochemistry means she specialises in complex technical disputes in the life sciences sector. She has more than fifteen years’ experience advising clients in patent litigation matters before the English Courts including securing preliminary injunctions. She is also experienced in advising on global cross-border litigation, and coordinating worldwide litigation, working closely with multi-disciplinary teams in the defence and enforcement of patent portfolios. She has developed innovative and successful strategies, often combining patent and regulatory law, to assist pharmaceutical companies in the enforcement of their rights.